Xiaoping Chen

4.9k total citations · 1 hit paper
124 papers, 2.9k citations indexed

About

Xiaoping Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Xiaoping Chen has authored 124 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Molecular Biology, 36 papers in Oncology and 29 papers in Cancer Research. Recurrent topics in Xiaoping Chen's work include RNA modifications and cancer (15 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Cancer-related molecular mechanisms research (10 papers). Xiaoping Chen is often cited by papers focused on RNA modifications and cancer (15 papers), Cancer, Hypoxia, and Metabolism (12 papers) and Cancer-related molecular mechanisms research (10 papers). Xiaoping Chen collaborates with scholars based in China, United States and Australia. Xiaoping Chen's co-authors include Bixiang Zhang, Huifang Liang, Liang Chu, Zhao Huang, Junnan Liang, Jin Chen, Jingyuan Wen, Wanguang Zhang, Zhanguo Zhang and Jia Song and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Xiaoping Chen

118 papers receiving 2.9k citations

Hit Papers

Neuroscience of cancer: unraveling the complex interplay ... 2025 2026 2025 5 10 15

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoping Chen China 31 1.6k 770 553 438 314 124 2.9k
Qizhi Wang China 27 2.0k 1.2× 544 0.7× 674 1.2× 240 0.5× 232 0.7× 135 3.0k
Cécile Guichard France 22 1.6k 1.0× 642 0.8× 311 0.6× 424 1.0× 430 1.4× 35 3.5k
Da Fu China 40 3.1k 1.9× 1.9k 2.4× 922 1.7× 433 1.0× 469 1.5× 165 5.0k
Xiaojie Lu China 34 2.1k 1.3× 1.1k 1.4× 758 1.4× 132 0.3× 307 1.0× 113 3.8k
Shuichi Fujioka Japan 27 1.4k 0.9× 606 0.8× 829 1.5× 563 1.3× 447 1.4× 81 2.8k
Jian Chen China 26 1.2k 0.7× 537 0.7× 521 0.9× 122 0.3× 291 0.9× 140 2.8k
Wei‐Hwa Lee Taiwan 29 1.5k 1.0× 641 0.8× 706 1.3× 122 0.3× 285 0.9× 99 3.0k
Changqing Su China 30 2.1k 1.3× 902 1.2× 672 1.2× 110 0.3× 190 0.6× 104 2.9k
Xinjian Lin China 29 1.3k 0.8× 594 0.8× 732 1.3× 154 0.4× 148 0.5× 82 2.5k

Countries citing papers authored by Xiaoping Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaoping Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Chen more than expected).

Fields of papers citing papers by Xiaoping Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoping Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Chen. The network helps show where Xiaoping Chen may publish in the future.

Co-authorship network of co-authors of Xiaoping Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoping Chen. A scholar is included among the top collaborators of Xiaoping Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoping Chen. Xiaoping Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhu, Chang, Huifang Liang, Zeyang Ding, et al.. (2025). Exon Skipping of Ste20- Like Kinase Enhances Glycolysis and Tumor Progression by Activating Enolase 1–Mediated Phosphoenolpyruvate Production. Cancer Research. 85(20). 3930–3948. 1 indexed citations
2.
Wang, Tianci, Ran Tao, Qiumeng Liu, et al.. (2025). TGM2-mediated histone serotonylation promotes HCC progression via MYC signalling pathway. Journal of Hepatology. 83(1). 105–118. 4 indexed citations
3.
Ping, Zhang, Ye Yuan, Xiaoping Chen, et al.. (2025). Neuroscience of cancer: unraveling the complex interplay between the nervous system, the tumor and the tumor immune microenvironment. Molecular Cancer. 24(1). 24–24. 16 indexed citations breakdown →
4.
Wu, Xing, et al.. (2024). B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications. Theranostics. 15(2). 605–631. 6 indexed citations
5.
Zhang, Wenxu, Yajuan Li, Anthony A. Fung, et al.. (2024). Multi-molecular hyperspectral PRM-SRS microscopy. Nature Communications. 15(1). 1599–1599. 24 indexed citations
6.
Huang, Tiantian, Pengfei Dang, Wen Wang, et al.. (2024). Enhancing wheat yield and nitrogen use efficiency in the Huang‐Huai‐Hai region of China: Insights from root biomass and nitrogen application responses. Journal of Agronomy and Crop Science. 210(1). 2 indexed citations
7.
Mo, Jie, Su Chen, Pengcheng Li, et al.. (2024). CKAP4 in hepatocellular carcinoma: competitive RETREG1/FAM134B binding, reticulophagy regulation, and cancer progression. Autophagy. 21(4). 840–859. 3 indexed citations
8.
Mao, Ninghui, Zeda Zhang, Young Sun Lee, et al.. (2021). Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers. Nature Communications. 12(1). 5053–5053. 18 indexed citations
9.
Zhu, He, Hongwei Zhang, Zhibin Liao, et al.. (2021). Long non-coding RNA CCDC183-AS1 acts AS a miR-589-5p sponge to promote the progression of hepatocellular carcinoma through regulating SKP1 expression. Journal of Experimental & Clinical Cancer Research. 40(1). 57–57. 20 indexed citations
10.
Wen, Shijie, Hao Liu, Xingyu Li, et al.. (2018). TALEN-mediated targeted mutagenesis of fatty acid desaturase 2 (FAD2) in peanut (Arachis hypogaea L.) promotes the accumulation of oleic acid. Plant Molecular Biology. 97(1-2). 177–185. 56 indexed citations
11.
Ma, Yu‐Shui, Zhi‐Jun Wu, Dong Hua, et al.. (2018). DRR1 promotes glioblastoma cell invasion and epithelial-mesenchymal transition via regulating AKT activation. Cancer Letters. 423. 86–94. 26 indexed citations
12.
Kudo, Masatoshi, Riccardo Lencioni, Jorge A. Marrero, et al.. (2016). Regional differences in sorafenib‐treated patients with hepatocellular carcinoma: GIDEON observational study. Liver International. 36(8). 1196–1205. 36 indexed citations
13.
Liu, Zhanji, Suping Feng, Manish K. Pandey, et al.. (2013). Identification of Expressed Resistance Gene Analogs from Peanut (Arachis hypogaea L.) Expressed Sequence Tags. Journal of Integrative Plant Biology. 55(5). 453–461. 11 indexed citations
14.
Sun, Zhengang, Zizhuo Zhao, Gaopeng Li, et al.. (2010). Relevance of Two Genes in the Multidrug Resistance of Hepatocellular Carcinoma: In Vivo and Clinical Studies. Tumori Journal. 96(1). 90–96. 45 indexed citations
15.
Li, Gaopeng, Shengli Dong, Zhengang Sun, et al.. (2009). Synergism of hydroxyapatite nanoparticles and recombinant mutant human tumour necrosis factor-α in chemotherapy of multidrug-resistant hepatocellular carcinoma. Liver International. 30(4). 585–592. 20 indexed citations
16.
Dong, Hanhua, Shuai Xiang, Xiaoping Chen, et al.. (2009). The Epithelial–Mesenchymal Transition Promotes Transdifferentiation of Subcutaneously Implanted Hepatic Oval Cells Into Mesenchymal Tumor Tissue. Stem Cells and Development. 18(9). 1293–1298. 14 indexed citations
17.
Li, Gaopeng, et al.. (2007). The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance. Journal of Huazhong University of Science and Technology [Medical Sciences]. 27(2). 173–175. 35 indexed citations
18.
Xiao, Zhenyu, Ya-Dan Wang, & Xiaoping Chen. (2006). [Effect of brain-derived neurotrophic factor on in vitro metastasis of hepatocellular carcinoma cell line HepG2].. PubMed. 25(3). 287–91. 2 indexed citations
19.
Chen, Xiaoping. (2006). Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells. World Journal of Gastroenterology. 12(21). 3332–3332. 17 indexed citations
20.
Jiang, Li, et al.. (2002). Diagnostic and therapeutic analysis to 5 cases of male breast cancer. The Chinese-German Journal of Clinical Oncology. 1(3). 175–176.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026